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Malignant transformation of cells is a complex 
process, which involves the accumulation of multiple 
independent mutations that lead to deregulation of cell 
signaling pathways that control cell growth, prolifera-
tion, differentiation and apoptosis [1]. Recent progress 
in biomedical sciences has identified a number of mo-
lecular pathways and cellular mechanisms that underline 
the multistage process of tumorogenesis and metastasis 
formation. It was shown that serine/threonine protein 
kinases could be involved in the integration of different 
signaling pathways in normal and malignant cells [2].
Protein kinase D (PKD) family within the group 
of calcium/calmodulin-dependent protein kinases 
(CAMK) consists of three members: PKD1/PKCμ, 
PKD2 and PKD3/PKCν. These kinases share high 
structural homology but differ in cell specific expres-
sion, intracellular distribution and, most probably, 
in substrate specificity and cellular function [2]. Full 
activation of PKD involves phosphorylation of Ser resi-
dues within different structural modules. Transphos-
phorylation sites in so-called “activation loop” of PKDs 
are substrate for PKCs phosphorylation. Autophos-
phorylation sites have been mapped in C-terminus 
of PKD1 and PKD2 and serves as indicator of kinase 
activation [3].
It is known that PKDs are activated by a range 
of cell surface receptors and pharmacological agents 
that could induce PKDs intracellular redistribution. 
PKD may be localized in the cytosol and in several 
intracellular compartments including nucleus, Golgi 
apparatus, plasma membrane and mitochondria. De-
pending on site of localization PKDs can be implicated 
in the regulation of a variety of cellular processes, 
including Golgi apparatus function and organization, 
receptors signalling, tumor cell spreading and moti-
lity that promote tumor invasion [2, 4].The presence 
of the nuclear translocation signal peptide may sug-
gest that upon stimulation PKDs are translocated 
into the nucleus and phosphorylate nuclear targets, 
such as histone deacetylases and histone chaperone 
SET [5]. Moreover, indirectly PKDs could be involved 
in activation of transcription factor NF-κB [6]. In this 
way, PKD kinases are implicated in epigenetic regula-
tion of gene expression [5].
PKD2 is the main serine/threonine protein kinase 
of PKD family, which is expressed in AGS cell line. In this 
cell line PKD2 is activated by gastrin and is a down-
stream target of PKCs [7, 8]. However, little is known 
about the expression and activity of PKD2 as well 
as PKD1 in primary gastric cancer cells.
H. pylori is a widespread chronic infection agent, 
that is considered to be aetiologycal factor for gastric 
and duodenal ulcer, MALT-lymphoma and gastric ade-
nocarcinoma [9]. At the same time, the role H. pylori 
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infection in pathogenesis of gastric cancer is not com-
pletely clarified.
Virulent H. pylori strains harbor a cagA pathogeni-
city island for delivery of the bacterial CagA protein into 
gastric epithelial cells [10, 11]. CagA is transported into 
the host target cells and subsequently phosphorylated. 
Clearly this is a mechanism by which H. pylori could take 
control of one or more host cell signal transduction path-
ways [10]. Presumably the final result of this interaction 
favors survival of H. pylori, irrespective of eventual da-
mage to the host cell. After translocation, CagA is phos-
phorylated by Src family kinases at the tyrosine residue 
in the EPIYA sequence repeats [12]. Phosphorylation 
of CagA is accompanied by high motility and elonga-
tion of cells, the so-called hummingbird phenotype 
[13]. CagA has been shown to interact with a number 
of host signaling molecules, such as the adaptor 
molecule Grb-2, tyrosine phosphatase SHP-2, Src, 
and C-terminal Src kinase (Csk) to induce inactivation 
of Src kinase and dephosphorylation of cortactin [14]. 
It was also shown, that infection by H. pylori induced 
signal transduction pathways that involve РКС kinases 
[15, 16]. PKCs phosphorylate and activate kinases 
of PKD family [3]. Taking into account that previously 
we have found heterogeneity in PKD1/2 autophos-
phorylation in gastric adenocarcinomas [17], in cur-
rent study we tested the hypothesis whether infection 
by the H. pylori may affect the level of PKD2 expression 
and/or activation in gastric cancer cells.
MATERIALS AND METHODS
Studies were performed on AGS cell line, gastric 
tumor samples and surrounding normal tissues of sto-
mach (29 cases of adenocarcinomas with different level 
of differentiation, 3 — cases of adenogenic cancer, 2 — 
cases of nondifferentiated cancer, 1 — case of carci-
noid tumor, 1 — case of adenoma). Gastric tumors were 
classified and graded according to WHO classification 
on the basis of combination of morphologic and clini-
cal characteristics [18]. The usage of tissue samples 
was approved by the Institutional Review Board and Re-
search Ethics Committee of R.E. Kavetsky Institute 
of Experimental Pathology, Oncology and Radiobiology, 
National Academy of Sciences of Ukraine.
Polyclonal rabbit antibodies, that recognize both 
PKD1 and PKD2 kinases (anti-PKD1/2) and auto-
phosphorylated sites in both PKD1 and PKD2 (anti-
pPKD1/2) (kind gift of Prof. VanLint, Belgium), PKD2 
(Calbiochem, USA), Ser876 in PKD2 (autophospho-
rylated pPKD2) (Upstate, USA), Ser 744/748 in PKD2 
(transphosphorylated ppPKD2) (Cell Signaling, USA) 
and goat anti-actin antibodies (Santa Cruz, CA, USA) 
were used as primary antibodies. EnVision detec-
tion system (DAKO, Denmark), goat anti-rabbit IgG-
HRP and donkey anti-goat IgG-HRP (Santa Cruz, CA, 
USA) were applied as a secondary antibodies.
Immunohistochemistry. Tissue samples of all 
studied cases were fixed in 4% paraformaldehyde 
and embedded in paraffin. Immunohistochemistry 
stu dies of PKD1 and PKD2 were performed on de-
paraffined tissues sections. We used specific anti-
PKD1/2 antibodies that recognized both isoforms. 
The levels of autophosphorylated PKD1 and PKD2 were 
used as a criterion of activated PKD1/2 and were ac-
cessed with anti-pPKD1/2 serum, which recognize con-
served autophosphorylation site in PKD1 and PKD2.
To reduce non-specific background, prior to spe-
cific antibodies, sections were treated with normal 
goat serum and 1% BSA solution. EnVision detection 
system was used in 45 min second-step incubation. 
After washing in phosphate-buffered saline peroxidase 
activity was assayed using DAB. Section were counter-
stained with hematoxylin for 1 min, embedded in balm, 
and studied under the microscope.
Isolation and cultivation of H. pylori. For isola-
tion we used samples of pyloric antrum of the sto-
mach from 4 patients with gastric ulcer (Department 
of Therapy № 2 of A.A. Bogomolets National Medical 
University, Kiev, Ukraine). For tissue sample trans-
portation we used Stuart’s transport medium (Merck, 
USA). Prior inoculation, material was homogenized 
in 0.5 ml of sterile PBS or brain heart infusion broth du-
ring 1 min. Selective medium Agar pylori (Bio Merieux, 
France) and nonselective — Columbia agar with 10% 
of the sheep blood (Bio Merieux, France) were ino-
culated with gomogenized tissues. Tissues dishes 
were incubated in GENbox Jar (Bio Merieux, France), 
in microaerofilic condition that was created by spe-
cial gas generation packages (Bio Merieux, France) 
at 37 °C during 7 days.
Typing of bacterial cultures was performed using 
cultural, morphological, tinctorial and enzymatic cri-
teria. Selected cultures of Н. pylori were subcultivated 
on Columbia agar with 10% of horse blood in microaero-
filic condition at 37 °C during 48–72 h. For inoculation 
of AGS cell line we used only “young” cultures of H. py-
lori, that had less than 25% of coccal forms and in size 
of the 108 CFU on Mac-Farland̓s scale.
Inoculation AGS cell line with Н. pylori. AGS cell 
line was cultivated with cagA– and cagA+ Н. pylori cultures 
during 4.5 h and proteins were extracted using Triton-
X100 lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 
1% Triton-X100, 5 mM EDTA) with cocktail of inhibitors 
of proteases and phosphatases (Sigma, USA).
Western blot analysis. Western blot analysis 
was performed using rabbit anti-PKD2, anti-ppPKD1/2 
(Ser 744/748), and anti-pPKD2 (Ser876) rabbit sera. 
The cells from cell cultures were lysed using Tri-
ton-X100 lysis buffer with cocktail of inhibitors of pro-
teases and phosphatases (Sigma, USA). Lysates were 
subjected to SDS-PAGE on 7.5% gels. Proteins were 
transferred to Immobilon-NC membranes (Millipore, 
USA) and blocked during overnight incubation with 5% 
nonfat dried milk in TBS-T. Membranes were incubated 
with primary antisera at 4 °C for 12 h and with seconda-
ry antibodies for 2 h. For semiquantitative evaluation 
of Western blot analysis Total lab software version 2.01 
(Phoretix, Nonlinear Dynamics Ltd) was applied.
DNA isolation and polymerase chain reaction 
for H. pylori identification. DNA isolation was per-
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formed using TRI reagent (Sigma, USA) according 
to manufacturers protocol. DNA pellet was dissolved 
in TE buffer. For polymerase chain reaction (PCR) 
we used 0.5 μg of DNA for each probe. The universal 
primers for H. pylori detection in gastric tissue included 
two oligonucleotides designed to amplify 16S rRNA 
(Maxim Biotech. Inc., USA), (GenBank Acession No.: 
U00679) the 5’Oligo: СTGGAGAGACTAAGCCCTCC 
and the 3ʼOligo: ATTACTGACGCTGATTGTGC, which 
generated a 110-bp product. PCR amplification with 
specific primers was performed according to standard 
protocol: thirty five cycles, with each cycle consis-
ting of denaturation step at 94 °C, annealing step 
at 58 °C and extension step at 72 °C. The specific pri-
mers for PCR amplification of cagA H. pylori (Helicopol 
Ca, Russia), which generated a 404-bp product, were 
used for identification of cagA+ strains of H. pylori. 
Thirty five cycles were performed, with each cycle 
consisting of denaturizing step at 94 °C, annealing 
step at 52 °C, and extension step at 72 °C. Each experi-
ment included negative and positive controls provided 
by manufacturers.
Statistical analysis. Statistical significance of dif-
ferences was evaluated by Student’s t-test.
RESuLTS AND DISCuSSION
Starting from our previous results that showed hete-
rogeneity of primary adenocarcinoma cancer samples 
by expression levels of PKD1 and PKD2 and auto-
phosphorylation/activation, we found that diffe rent 
histological variants of gastric cancer also vary 
in the level of PKD1/2 autophosphorylation. The high 
level of PKD1/2 autophosphorylation was detected 
in adenocarcinomas with moderate level of differ-
entiation (Fig. 1, a), whereas in adenogenic cancer 
the level of PKD1/2 autophosphorylation was very 
low or undetectable (Fig. 1, b). At the same time, 
benign tumor (adenoma) demonstrated high level 
of PKD1/2 autophosphorylation (Fig. 1, с). Heteroge-
neity of gastric cancer primary samples by PKD1/2 au-
tophosphorylation could depend not only on the level 
of cell differentiation [17], but also reflect tumor cell 
activation with infectious agents. Since H. pylori in-
fection was shown to trigger PKC-mediated signaling 
pathway [15, 16], and activity (autophosphorylation) 
of PKD kinases is regulated by PKCs [2, 19], we ana-
lyzed the pre sence of H. pylori in the primary gastric 
tumor samples and addressed the question whether 
H. pylori could induce PKD phosphorylation.
The 16S rRNA gene of H. pylori is a highly specific 
target for amplification and has been used previously 
to help reclassify these bacteria [20]. Weiss et al. [21] 
have demonstrated the specificity of unique H. pylori 
16S rRNA gene primers to identify the bacteria in pa-
raffin-embedded gastric biopsy specimens. In primary 
tissue samples we found that 97% (35 from 36) cases 
of examined gastric tumors contain H. pylori 16S rRNA 
(Fig. 2, a) that is comparable to the previously pub-
lished data [22].
a
b
c
Fig. 1. The level of PKD1/2 autophosphorylation in gastric 
tumors, immunohistochemical staining. a, adenocarcinoma; 
b, adenogenic cancer; c, adenoma (X400)
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16s RNA
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Fig. 2. PCR analysis of DNA isolated from gastric tissue samples. 
The presense of 16S rRNA (a) of H. pylori identify the bacteria 
from frozen (1–4, 7) and in paraffin-embedded gastric biopsy 
specimens (5–6, 8). b, cagA+ from H. pylori. c, Control of assayed 
material (DNA). 1–5 — adenocarcinomas, 6 — adenogenic can-
cer, 7 — carcinoid cancer, 8 — nondifferentiated gastric cancer, 
9 — positive control
Some strains of H. pylori have been shown to be more 
pathogenic than others. Strains that possess CagA 
are associated with increased severity of gastritis 
and with additional risk for developing atrophic gastritis 
and gastric cancer [23]. Moreover, it has been demon-
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strated that after H. pylori infection, CagA is translocated 
into the epithelial cells, and it undergoes tyrosine phos-
phorylation in the host cells. The phosphorylated form 
of CagA might function as a phosphatase that regulates 
host cell growth [24]. As we can find out, cаgA gene 
was detected in 83% (30 from 36) cases of primary 
tumor tissue samples (Fig. 2, b). It should be noted that 
H. pylori cagA+ was revealed in all tested 29 adenocarci-
noma samples as well as gastric adenoma tissue sample 
(see Fig. 2, a, b, tracks 1–5; other data not shown). 
In two samples of adenogenic cancer cagA– gene H. py-
lori was identified, however one case of adenogenic 
cancer can be considered as H. pylori negative, since 
H. pylori 16S rRNA gene was not detected here (see 
Fig. 2, a, b, track 6 and data not shown). In carcinoid 
and nondifferentiated gastric cancer we found the pre-
sence of H. pylori, with very low numbers of cagA copies 
(see Fig.2 a, b, tracks 7 and 8).
Since in our studies the presence of cagA+ H. pylori 
in tumor tissues was correlated with the moderate 
to high level of PKD1/2 autophosphorylation, we ad-
dressed the question whether H. pylori infection 
may affect the level of PKD2 expression and/or trans- 
and autophosphorylation. To test this hypothesis 
we used the model gastric cancer cell line AGS which 
was infected with H. pylori. Cultivation of AGS cell 
line with cagA– or cagA+ H. pylori cultures during 
4.5 h caused the elevation of PKD2 expression level 
in comparison with the control cultures, moreover, 
it resulted in PKD2 transphosphorylation (ppPKD2) 
and autophosphorylation (pPKD2) (Fig. 3).
Control cell culture did not demonstrate PKD2 trans-
phosphorylation that is PKC-dependent. PKD2 in these 
cultures was not activated and, accordingly, was not auto-
phosphorylated (see Fig. 3, a). At the same time, ino-
culation of AGS cell line with H. pylori led to substantial 
PKD2 trans- and autophosphorylation reflecting the acti-
vation of this kinase. Furthermore, the level of PKD2 auto-
phosphorylation in AGS cell line inoculated with cagA+ 
H. pylori was much higher than that in cells inocula ted 
with cagA– H. pylori (see Fig. 3, a). To evaluate H. рylori 
induced changes in PKD2 expression and phosphoryla-
tion we have performed densitometric analysis of Western 
blots with normalization to the level of actin expression 
(see Fig. 3, b). As it is shown on the left panel of Fig. 3, b, 
infection with cagA– and cagA+ of H. рylori led to elevation 
of PKD2 expression by 3.29 and 3.66 times respectively 
(p < 0.001). H. рylori infection dramatically increased both 
trans- and autophosphorylation of PKD2. It worth to note 
that in cultures with cagA+ H. рylori the level of transpho-
sphorylation (PKC-dependent) was by 1.39 times higher 
than in cultures infected with cagA– H. рylori (p < 0.001). 
For PKD2 autophosphorylation this difference was even 
higher — 3.27 times (p < 0.001) (see Fig. 3, middle 
and right panel).
The development of cancer is often associated 
with chronic inflammation [25]. Inflammation is linked 
to all stages of tumor development — initiation, progres-
sion and metastasis. Although the connection between 
chronic inflammation and cancerogenesis has been well 
established, the underlying mechanisms remain unclear 
[25]. Recent studies have begun to unravel signaling 
pathways linking inflammation and cancer [26].
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Fig. 3. Protein expression, trans- and autophosphorylation 
of PKD2 in AGS cell line after H. pylori infection. a, Western blot 
analysis of PKD2 expression, transphosphorylation (ppPKD1/2), 
and autophosphorylation (pPKD2). The level of actin expression 
served as loading control. Control — noninfected AGS cell line, 
cagA– — AGS cell line infected with cagA– culture of H. pylori. 
cagA+ — AGS cell line infected with cagA+ culture of H. pylori. 
b, Densitometry of Western blot analysis with normalization 
to actin (p < 0.001)
H. pylori that infects over half of the world’s popu-
lation, usually persists in the gastric mucosa [27] 
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and confers risk of serious diseases, including peptic 
ulceration and gastric neoplasia [28]. Н. pylori is the first 
bacterium to be classified as a definite carcinogen 
because of its epidemiologic relationship to gastric 
adenocarcinoma and gastric mucosa-associated lym-
phoid tissue MALT lymphoma. Understanding how this 
bacteria interacts with its host and affects biological 
functions of epithelial cells via interaction with different 
intracellular signaling pathways is essential for desig-
ning the strategy for optimized therapy [29].
Recently the mechanisms H. pylori interaction with 
host cells have been clarified. H. pylori possesses over 
30 genes related to the expression of outer membrane 
proteins. Several of these proteins have been classi-
fied as adhesins, suggesting multiple and perhaps 
redundant or variable modes of attachment to cell 
surface. The best studied H. pylori adhesins are outer 
membrane proteins that bind carbohydrate moie-
ties in host cell glycoproteins [29]. Bacterium also 
use CD74 for adhesion to epithelial cells [30].
There are known several distal outcomes of H. pylori 
interaction with gastric epithelial cell for example, activa-
tion of transcription factors NF-κB and АР-1, induction 
of secretion of MIF, IL-8, IL-1β [30, 31], but the mecha-
nisms of signal transduction and intracellular pathways 
utilized by this bacterium was not explored.
In our studies we tested the hypothesis whether 
cagA+ and cagA– H. pylori can affect the PKD2 expres-
sion and activation.
Our study revealed the presence of H. pylori 
in all exa mined 29 adenocarcinoma samples that 
are characterized by high and moderate level 
of PKD1/2 autophosphorylation. Moreover, all these 
cases also were cagA+. Adenogenic and nondif-
ferentiated gastric cancer, and also carcinoid ones 
had very low level of PKD1/2 aurophosphoryla-
tion and are cagA– or carry low numbers of cagA. 
At the same time, benign tumor (adenoma) de-
monstrated high level of PKD1/2 autophosphorylation 
and the presence of cagA+ H. pylori. Heterogeneity 
of primary gastric cancer samples in PKD1/2 auto-
phosphorylation could depend on the level of cell 
differentiation, but also reflect tumor cell activation 
with infectious agents. Althoug the percent of H. pylori 
positive gastric samples vary depending on age, geo-
graphical localization and ethnicity, H. pylori was de-
tected in vast majority of adenocarcinoma samples 
[27, 32]. According to our data, H. pylori was detected 
in all tested adenocarcinoma samples, moreover, 
all studied adenocarcinoma cases were cagA+.
Correlation between the presence of cagA posi-
tive H. pylori and PKD1/2 phosphorylation may point 
on causal link between infection and PKDs activation. 
To test this assumption we employed experimental 
model system. Indeed, H. pylori infection of AGS cell 
line induced autophosphorylation/activation of PKD2 
(see Fig. 3). This activation was PKC-dependent, since 
PKD2 was phosphorylated at site Ser 744/748, which 
is the target of PKC (see Fig. 3). Moreover, we found 
that infection with either cagA– and cagA+ H. pylori also 
elevated the level of PKD2 expression in AGS cell line. 
Markedly, the cagA+ H. pylori was more potent than 
cagA– H. pylori in elevation of PKD2 level (see Fig. 3, a). 
It is obvious that increase of PKD2 activity was not de-
pendent on the level of PKD2 expression since in con-
trol cultures PKD phosphorylation was not detected.
There are several lines of evidence of the functional 
link between H. pylori infection and PKDs activation. 
First, H. pylori infection was shown to trigger PKC-
mediated signaling pathway [15, 16], and PKCs regu-
late activity (autophosphorylation) of PKD kinases [2, 
19]. Second, both H. pylori and PKDs are involved in 
NF-κB activation [27, 30]. Third, CagA targets an im-
portant cellular E-cadherin/β-catenin pathway, which 
regulates epithelial junction formation, epithelial cell 
adhesion, and control cell growth [33]. PKDs activity 
is also involved in regulation of E-cadherin/β-catenin 
pathway especially in tumor cells [34]. Fourth, both 
PKDs and H. pylori are linked to regulation of HDAC 
(histon deacetylases), which are involved in epigenetic 
regulation of gene expression [28, 35]. Fifth, both regu-
late matrix metalloproteinase expression [36–38].
All these suggest that in order to affect host cell bio-
logical programs, H. pylori may use PKDs-mediated 
signalling pathways.
In conclusion, using the model system of gastric 
cancer cell line AGS we have shown that H. pylori 
infection enhanced the levels of expression, trans- 
and autophosphorylation of protein kinase PKD2, that 
may lead to activation of signal transduction path-
ways, promoting cell proliferation and tumor invasion. 
We also found that the level of PKD2 autophosphoryla-
tion/activation was higher in AGS cell line inoculated 
of with cagA+ H. pylori than that in AGS cells with cagA– 
H. pylori. H. pylori induced activation of PKD1/2 could 
contribute to the pathogenesis of gastric cancer.
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